Medtronic's next-gen renal denervation catheter and procedure are in the works to advance the FDA-approved Symplicity Spyral ...

Shares of Medtronic (NYSE: MDT) are off to a fantastic start in 2025, already rising by 13% year to date. The medical devices ...

This was the stock's third consecutive day of gains.

If you're a dividend investor, I can understand why -- because dividend-paying stocks offer a triple upside: As long as the ...